Endoscopic Retrograde Cholangiopancreatography Ercp Market: Market Size & Forecast 2026

ERCP combines endoscopy and fluoroscopy to diagnose and treat conditions affecting the biliary and pancreatic ductal systems. The global market encompasses diagnostic and therapeutic devices including duodenoscopes, guidewires, catheters, biliary stents, and sphincterotomes, alongside consumables and accessories required for procedural execution. The $2.15 billion market reflects sustained demand from both diagnostic and increasingly therapeutic applications, with hospitals and specialized endoscopy centers comprising the primary customer base.

• •Market valued at approximately $2.15 billion in 2025
• •Procedures performed across hospital endoscopy units and ambulatory surgical centers
• •Therapeutic ERCP applications growing faster than diagnostic-only segments

The aging global population is a primary structural driver, as biliary and pancreatic disorders such as choledocholithiasis, pancreatic cancer, and cholangiocarcinoma exhibit significantly higher prevalence in older age cohorts. Rising obesity rates and associated gallstone disease further expand the addressable patient population. Clinical advances in stent technology, including biodegradable and fully covered metal stents, along with ultrasound-guided and enteroscopy-assisted ERCP techniques, are broadening procedural indications and improving safety profiles. Increasing procedural volumes tracked through healthcare utilization databases and payer claims data confirm sustained adoption trends.

• •Aging demographics driving higher incidence of biliary and pancreatic diseases
• •Technological advances in stenting and accessories expanding therapeutic indications
• •Rising healthcare utilization data confirming growing ERCP procedural volumes

The market is broadly segmented by product type, including duodenoscopes, accessories and consumables, and biliary stents, with stenting representing a high-growth segment due to demand for both plastic and metal stent variants. Geographically, North America leads the market, supported by advanced healthcare infrastructure, high procedure volumes, and strong payer coverage through Medicare and private insurance plans. Europe and the Asia-Pacific region represent significant and growing markets, with Asia-Pacific showing notably faster growth due to expanding healthcare access and rising disease burden. Emerging markets in Latin America and the Middle East are contributing to overall market expansion as endoscopic capabilities improve.

• •North America leads, supported by Medicare and private insurance coverage
• •Asia-Pacific is the fastest-growing regional market due to expanding healthcare access
• •Biliary stents and therapeutic accessories are the highest-growth product categories

What are the recent trends and outlook?

Emerging trends point toward continued growth through 2030, with endoscopic ultrasound-guided alternatives increasingly positioned as complementary or substitute technologies for certain biliary and pancreatic interventions. Innovation in fully disposable duodenoscopes and single-use accessories is accelerating, driven by infection control priorities and regulatory guidance. Artificial intelligence-assisted imaging and robotics-assisted endoscopy represent longer-term developments with potential to reshape procedural workflows. Clinical research into reducing complications such as post-ERCP pancreatitis and managing the significant associated healthcare costs will continue to influence both clinical practice patterns and device demand. Competitive endoscopy techniques, including EUS-guided gallbladder drainage and transmural interventions, are expanding the broader biliary therapeutic ecosystem while reinforcing ERCP's role as a foundational procedure.

• •Single-use and disposable duodenoscope technologies gaining regulatory and clinical momentum
• •EUS-guided biliary interventions emerging as competitive and complementary alternatives
• •AI-assisted imaging and robotics represent longer-term innovation frontiers